# Giuseppe Remuzzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giuseppe-remuzzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 323,461 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 204 |
| i10-index | 1,235 |
| Last Known Institution | Mario Negri Institute for Pharmacological Research |
| OpenAlex ID | https://openalex.org/A5023556434 |
| ORCID iD | 0000-0002-6194-3446 |
| Works | 2,091 |

## Researcher papers

Showing 12 of 39.

- [Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/effects-of-losartan-on-renal-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/a-trial-of-darbepoetin-alfa-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology](https://scholariq.org/papers/international-society-of-nephrology-s-0by25-initiative-for-acute-kidney-injury/)
- [Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype](https://scholariq.org/papers/relative-role-of-genetic-complement-abnormalities-in-sporadic-and-familial-ahus/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease](https://scholariq.org/papers/bardoxolone-methyl-in-type-2-diabetes-and-stage-4-chronic-kidney-disease/)
- [Chronic kidney disease](https://scholariq.org/papers/chronic-kidney-disease-3/)
- [Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL](https://scholariq.org/papers/proteinuria-a-target-for-renoprotection-in-patients-with-type-2-diabetic/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria](https://scholariq.org/papers/renoprotective-properties-of-ace-inhibition-in-non-diabetic-nephropathies-with/)
- [Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy](https://scholariq.org/papers/albuminuria-a-therapeutic-target-for-cardiovascular-protection-in-type-2/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Mario Negri Institute for Pharmacological Research](https://scholariq.org/institutions/mario-negri-institute-for-pharmacological-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.